EUCTR2021-006796-41-NL进行中（未招募）1 期
A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using intravenous bevacizumab-800CW - IBIZA-2(pilot)
Meander Medical Centre0 个研究点目标入组 5 人开始时间: 2022年7月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Oral and written informed consent (IC)
- •- Aged 18 years and older
- •- Pathologically confirmed and/or suspected cT1-3N0-2M0 colon carcinoma
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 3
排除标准
- •- Distant metastasis
- •- Suspicion of cT4 disease based on pre-operative assessment
- •- Metastatic or T4 disease discovered during intraoperative staging
- •- Pregnancy, lactation or a planned pregnancy during the course of the
- •- Previous colon surgery, excluding appendectomy.
- •- Contra-indication for laparoscopic/robotic surgery
- •- Inadequately controlled hypertension with or without current antihypertensive medication.
- •- Within 6 months prior to inclusion: myocardial infarction, TIA, CVA, pulmonary embolism, unstable angina pectoris, or uncontrolled chronic hepatic failure.
- •- Regarding bevacizumab: Hypersensitivity to Chinese Hamster Ovary
- •(CHO) cell products or other recombinant human or humanised
- •antibodies. Or an allergy for its components (Trehalose dehydrate,
- •sodium phosphate, polysorbate 20, water for injections)
研究者
相似试验
招募中
1 期
A pilot study of patients with oligometastases from breast cancer treated with stereotactic ablative body radiosurgery in combination with the anti-PD-1 antibody MK-3475.Metastatic Breast Cancer (1-5 metastases)Cancer - BreastCancer - BoneACTRN12614001181695Peter MacCallum Cancer Centre15
招募中
不适用
A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using Indocyanine green.NL-OMON24349Meander Medical Centre, Department of Surgery10
已完成
不适用
A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using intravenous bevacizumab-800CWcolon carcinomaintestinal cancer1001799010017991NL-OMON53524Meander Medisch Centrum5
进行中（未招募）
1 期
Identification of the sentinel lymph node (SLN) in patients with colon carcinoma.Colon carcinomaEUCTR2021-006700-32-NLMeander Medical Centre5
已完成
不适用
A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using submucosal bevacizumab-800CWNL-OMON51330Meander Medisch Centrum5